Why the study?
The study evaluated the risk of syncopal recurrences after pacemaker implantation in patients with syncope of suspected bradyarrhythmic aetiology.
Does establishing a syncope-ECG correlation before pacemaker implantation reduce the risk of syncopal recurrences in patients with suspected bradyarrhythmic syncope?
Does establishing a syncope-ECG correlation before pacemaker implantation reduce the risk of syncopal recurrences in patients with suspected bradyarrhythmic syncope?
Establishing a symptom-ECG correlation prior to pacemaker implantation for suspected bradyarrhythmic syncope is associated with a significantly lower risk of syncopal recurrences.
Answers are grounded in this paper and cite their sources.
Correlating symptoms with documented bradyarrhythmia before pacing may reduce recurrences; leaves open need for randomized trials to guide syncope work-up.
AIMS: To evaluate the risk of syncopal recurrences after pacemaker implantation in a population of patients with syncope of suspected bradyarrhythmic aetiology. METHODS AND RESULTS: Prospective, multicentre, observational registry enrolling 1364 consecutive patients undergoing pacemaker implantation for syncope of bradyarrhythmic aetiology (proven or presumed). Before pacemaker implantation, all patients underwent a cardiac work-up in order to establish the bradyarrhythmic aetiology of syncope. According to the results of the diagnostic work-up, patients were divided into three groups: Group A, patients in whom a syncope-electrocardiogram (ECG) correlation was established (n = 329, 24.1%); Group B, those in whom clinically significant bradyarrhythmias were detected without a documented syncope-ECG correlation (n = 877, 64.3%); and Group C, those in whom bradyarrhythmias were not detected and the bradyarrhythmic origin of syncope remained presumptive (n = 158, 11.6%). During a median follow-up of 50 months, 213 patients (15.6%) reported at least one syncopal recurrence. Patients in Groups B and C showed a significantly higher risk of syncopal recurrences than those in Group A [hazard ratios (HRs): 1.60 and 2.66, respectively, P < 0.05]. Failure to establish a syncope-ECG correlation during diagnostic work-up before pacemaker implantation was an independent predictor of syncopal recurrence on multivariate analysis (HR: 1.90; P = 0.002). CONCLUSION: In selecting patients with syncope of suspected bradyarrhythmic aetiology for pacemaker implantation, establishing a correlation between syncope and bradyarrhythmias maximizes the efficacy of pacing and reduces the risk of syncopal recurrences.
No takes yet. Share an insight, caveat, or question.
Palmisano et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: